Search


The Co-Founder of AI Proteins explains the benefits of designing de novo miniproteins as therapeutics
Chris Bahl walks through the attributes of miniproteins.
Apr 25, 2024
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.